Journal of the science of food and agriculture · 2026
Synthesis, characterization, and iron supplementation effects of egg yolk phosphopeptide-ferrous chelate.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Junhua, Chen Hanqi, Zhang Jinping, Yang Yanjun, Su Yujie, Gu Luping, Chang Cuihua
Аннотация
BACKGROUND: Iron-deficiency anemia (IDA) persists as a global public health burden, urging the development of high-efficacy iron supplements with improved bioavailability and stability. Egg yolk phosphopeptides (EYPPs) possess excellent metal-chelating potential due to their abundant functional groups, making them ideal carriers for iron fortification.
RESULTS: This study synthesized and characterized an egg yolk phosphopeptide-ferrous (EYPP-Fe) chelate, optimizing reaction conditions as follows: 7.5% peptide concentration, 3:1 peptide-to-iron salt mass ratio, 55 °C reaction temperature, pH 7, and 40 min reaction time. Structural analyses via ultraviolet-visible, fluorescence, X-ray diffraction, thermogravimetric analysis, and Fourier transform infrared spectroscopy confirmed chelate formation, with ferrous ions coordinating with EYPP's amino, carboxyl, and phosphate groups. In vitro assays demonstrated EYPP-Fe's robust stability against heat, salt, acid, and gastrointestinal digestion. In a zebrafish model of phenylhydrazine-induced anemia, EYPP-Fe significantly ameliorated anemia (P < 0.05), increasing cardiac erythrocyte staining intensity by 78.57% compared to the model group - outperforming ferrous pyrophosphate.
CONCLUSION: These findings validate EYPP-Fe as a promising iron supplement candidate with enhanced stability and bioavailability, offering a viable solution for IDA mitigation. © 2026 Society of Chemical Industry.
RESULTS: This study synthesized and characterized an egg yolk phosphopeptide-ferrous (EYPP-Fe) chelate, optimizing reaction conditions as follows: 7.5% peptide concentration, 3:1 peptide-to-iron salt mass ratio, 55 °C reaction temperature, pH 7, and 40 min reaction time. Structural analyses via ultraviolet-visible, fluorescence, X-ray diffraction, thermogravimetric analysis, and Fourier transform infrared spectroscopy confirmed chelate formation, with ferrous ions coordinating with EYPP's amino, carboxyl, and phosphate groups. In vitro assays demonstrated EYPP-Fe's robust stability against heat, salt, acid, and gastrointestinal digestion. In a zebrafish model of phenylhydrazine-induced anemia, EYPP-Fe significantly ameliorated anemia (P < 0.05), increasing cardiac erythrocyte staining intensity by 78.57% compared to the model group - outperforming ferrous pyrophosphate.
CONCLUSION: These findings validate EYPP-Fe as a promising iron supplement candidate with enhanced stability and bioavailability, offering a viable solution for IDA mitigation. © 2026 Society of Chemical Industry.